Selected publications
-
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
Leukemia & lymphoma.
2012
Academic Article
GET IT
Times cited: 6 -
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
Breast cancer research and treatment.
2012
Academic Article
GET IT
Times cited: 12 -
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer.
Cancer.
2011
Academic Article
GET IT
Times cited: 13